Literature DB >> 9259589

Dynamics of HIV-1 mRNA expression in patients with long-term nonprogressive HIV-1 infection.

M Comar1, C Simonelli, S Zanussi, P Paoli, E Vaccher, U Tirelli, M Giacca.   

Abstract

A large number of evidences indicate that progression of HIV disease is driven by an increase in viral burden. It is still unclear, however, to what extent this is contributed by the dysregulation of the molecular mechanisms governing virus gene expression at the transcriptional or posttranscriptional levels. To address this issue, several quantitative virologic parameters (including provirus transcriptional activity and splicing pattern) were analyzed in individuals with nonprogressive HIV infection and compared with those of a matched group of progressor patients. Exact quantification was achieved by a competitive PCR procedure using a multicompetitor template. Nonprogressors were characterized by striking differences in the levels of viremia, provirus copy number, and overall levels of all viral mRNA classes in peripheral blood mononuclear cells. Additionally, the transcriptional activity of the proviral DNA in these patients was mainly engaged in the production of multiprocessed transcripts, with a pattern resembling the early phases of the experimental infection. Taken together, these results show that both viral load and provirus transcription pattern are remarkably different in infected individuals nonprogressing toward overt disease, and further support the notion that disease progression is accompanied by a change in the kinetics of HIV gene expression.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9259589      PMCID: PMC508262          DOI: 10.1172/JCI119605

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  58 in total

1.  Quantitative analysis of hepatitis C virus RNA in liver biopsies by competitive reverse transcription and polymerase chain reaction.

Authors:  G Grassi; G Pozzato; M Moretti; M Giacca
Journal:  J Hepatol       Date:  1995-10       Impact factor: 25.083

2.  Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection.

Authors:  F Kirchhoff; T C Greenough; D B Brettler; J L Sullivan; R C Desrosiers
Journal:  N Engl J Med       Date:  1995-01-26       Impact factor: 91.245

3.  Studies in subjects with long-term nonprogressive human immunodeficiency virus infection.

Authors:  G Pantaleo; S Menzo; M Vaccarezza; C Graziosi; O J Cohen; J F Demarest; D Montefiori; J M Orenstein; C Fox; L K Schrager
Journal:  N Engl J Med       Date:  1995-01-26       Impact factor: 91.245

4.  Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection.

Authors:  Y Cao; L Qin; L Zhang; J Safrit; D D Ho
Journal:  N Engl J Med       Date:  1995-01-26       Impact factor: 91.245

5.  Defective accessory genes in a human immunodeficiency virus type 1-infected long-term survivor lacking recoverable virus.

Authors:  N L Michael; G Chang; L A d'Arcy; P K Ehrenberg; R Mariani; M P Busch; D L Birx; D H Schwartz
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

6.  HIV-1 messenger RNA in peripheral blood mononuclear cells as an early marker of risk for progression to AIDS.

Authors:  K Saksela; C E Stevens; P Rubinstein; P E Taylor; D Baltimore
Journal:  Ann Intern Med       Date:  1995-11-01       Impact factor: 25.391

7.  Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long-term nonprogressors.

Authors:  D C Montefiori; G Pantaleo; L M Fink; J T Zhou; J Y Zhou; M Bilska; G D Miralles; A S Fauci
Journal:  J Infect Dis       Date:  1996-01       Impact factor: 5.226

8.  Changes in the viral mRNA expression pattern correlate with a rapid rate of CD4+ T-cell number decline in human immunodeficiency virus type 1-infected individuals.

Authors:  M R Furtado; L A Kingsley; S M Wolinsky
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

9.  Absence of recoverable infectious virus and unique immune responses in an asymptomatic HIV+ long-term survivor.

Authors:  D Schwartz; U Sharma; M Busch; K Weinhold; T Matthews; J Lieberman; D Birx; H Farzedagen; J Margolick; T Quinn
Journal:  AIDS Res Hum Retroviruses       Date:  1994-12       Impact factor: 2.205

10.  In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency.

Authors:  T W Chun; D Finzi; J Margolick; K Chadwick; D Schwartz; R F Siliciano
Journal:  Nat Med       Date:  1995-12       Impact factor: 53.440

View more
  11 in total

1.  Low plasma human immunodeficiency virus type 2 viral load is independent of proviral load: low virus production in vivo.

Authors:  S J Popper; A D Sarr; A Guèye-Ndiaye; S Mboup; M E Essex; P J Kanki
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

2.  Effects of subcutaneous interleukin-2 therapy on CD4 subsets and in vitro cytokine production in HIV+ subjects.

Authors:  P De Paoli; S Zanussi; C Simonelli; M T Bortolin; M D'Andrea; C Crepaldi; R Talamini; M Comar; M Giacca; U Tirelli
Journal:  J Clin Invest       Date:  1997-12-01       Impact factor: 14.808

3.  Changes in thymic function in HIV-positive patients treated with highly active antiretroviral therapy and interleukin-2.

Authors:  P De Paoli; M T Bortolin; S Zanussi; A Monzoni; C Pratesi; M Giacca
Journal:  Clin Exp Immunol       Date:  2001-09       Impact factor: 4.330

4.  Transcriptional suppression of in vitro-integrated human immunodeficiency virus type 1 does not correlate with proviral DNA methylation.

Authors:  Marjorie Pion; Albert Jordan; Angelique Biancotto; Franck Dequiedt; Françoise Gondois-Rey; Sophie Rondeau; Robert Vigne; Jiri Hejnar; Eric Verdin; Ivan Hirsch
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

5.  HIV-1 tat transactivator recruits p300 and CREB-binding protein histone acetyltransferases to the viral promoter.

Authors:  G Marzio; M Tyagi; M I Gutierrez; M Giacca
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

Review 6.  Measuring the Size of the Latent Human Immunodeficiency Virus Reservoir: The Present and Future of Evaluating Eradication Strategies.

Authors:  Timothy J Henrich; Steven G Deeks; Satish K Pillai
Journal:  J Infect Dis       Date:  2017-03-15       Impact factor: 5.226

7.  Sequence Analysis of In Vivo-Expressed HIV-1 Spliced RNAs Reveals the Usage of New and Unusual Splice Sites by Viruses of Different Subtypes.

Authors:  Yolanda Vega; Elena Delgado; Jorge de la Barrera; Cristina Carrera; Ángel Zaballos; Isabel Cuesta; Ana Mariño; Antonio Ocampo; Celia Miralles; Sonia Pérez-Castro; Hortensia Álvarez; Isabel López-Miragaya; Elena García-Bodas; Francisco Díez-Fuertes; Michael M Thomson
Journal:  PLoS One       Date:  2016-06-29       Impact factor: 3.240

8.  Cell-Associated HIV-1 Unspliced-to-Multiply-Spliced RNA Ratio at 12 Weeks of ART Predicts Immune Reconstitution on Therapy.

Authors:  Mirte Scherpenisse; Neeltje A Kootstra; Margreet Bakker; Ben Berkhout; Alexander O Pasternak
Journal:  mBio       Date:  2021-03-09       Impact factor: 7.867

Review 9.  Cell-associated HIV RNA: a dynamic biomarker of viral persistence.

Authors:  Alexander O Pasternak; Vladimir V Lukashov; Ben Berkhout
Journal:  Retrovirology       Date:  2013-04-15       Impact factor: 4.602

Review 10.  What do we measure when we measure cell-associated HIV RNA.

Authors:  Alexander O Pasternak; Ben Berkhout
Journal:  Retrovirology       Date:  2018-01-29       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.